Meuronen, Topi http://orcid.org/0000-0002-8856-0680
Lankinen, Maria A.
Kärkkäinen, Olli
Laakso, Markku
Pihlajamäki, Jussi
Hanhineva, Kati
Schwab, Ursula
Clinical trials referenced in this document:
Documents that mention this clinical trial
FADS1 rs174550 genotype and high linoleic acid diet modify plasma PUFA phospholipids in a dietary intervention study
https://doi.org/10.1007/s00394-021-02722-w
Funding for this research was provided by:
Pohjois-Savon Rahasto
Biotieteiden ja Ympäristön Tutkimuksen Toimikunta (309311, 334814, 321716)
Juho Vainion Säätiö
The University of Eastern Finland Spearhead Funding
University of Eastern Finland (UEF) including Kuopio University Hospital
Article History
Received: 17 June 2021
Accepted: 18 October 2021
First Online: 31 October 2021
Declarations
:
: Olli Kärkkäinen and Kati Hanhineva are founders of Afekta Technologies Ltd., a company providing metabolomics analysis services. Other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: The study plan was approved by the Ethical Committee of the Hospital District of Northern Savo (75//2014).
: Written informed consent was obtained from all participants.
: All authors reviewed and approved the final version of the manuscript.